Immune transfer protects severely immunosuppressed mice from murine cytomegalovirus retinitis and reduces the viral load in ocular tissue

Journal of Infectious Diseases

Volumn 182, Issue 3, 2000, Pages 652-661

  Kercher, Lisa ^a   Mitchell, Bradley M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DENSITOMETRY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINITIS; SCORING SYSTEM; VIRUS LOAD;

ADOPTIVE TRANSFER; ANIMALS; CYCLOPHOSPHAMIDE; CYTOMEGALOVIRUS RETINITIS; DISEASE MODELS, ANIMAL; EYE; FEMALE; IMMUNOSUPPRESSION; LYMPH NODES; MICE; MICE, INBRED BALB C; MUROMEGALOVIRUS; PLAQUE ASSAY; POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 0033827302     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315781     Document Type: Article

References (45)

1. Cytomegalovirus
2. Cytomegalovirus and its role in the pathogenesis of acquired immune deficiency syndrome
3. Cell types involved in replication and distribution of human cytomegalovirus
4. Diagnosis and treatment of cytomegalovirus retinitis
5. Acquired immune deficiency syndrome and the eye - 1996
6. AIDS and ophthalmology: A period of transition
7. Cytomegalovirus retinitis and the evolving AIDS epidemic
8. Changing trends in cytomegalovirus retinitis with triple therapy
9. Murine cytomegalovirus
10. Retinitis in euthymic mice following inoculation of murine cytomegalovirus (MCMV) via the supraciliary route
11. Necrotizing retinopathy after intraocular inoculation of murine cytomegalovirus in immunosuppressed adult mice
12. T-cell depletion increases susceptibility to murine cytomegalovirus retinitis
13. Dissemination and replication of MCMV after supraciliary inoculation in immunosuppressed BALB/c mice
14. Control of cytomegalovirus in bone marrow transplantation chimeras lacking the prevailing antigen-presenting molecule in recipient tissues rests primarily on recipient-derived CD8 T-cells
15. Control of murine cytomegalovirus in the lungs: Relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates
16. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells
17. Adoptive transfer of murine cytomegalovirus-immune lymph node cells prevents retinitis in T-cell depleted mice
18. Immune privilege and suppression of immunogenic inflammation in the anterior chamber of the eye
19. Immunoregulatory mechanisms of the eye
20. NK cell modulation of murine cytomegalovirus retinitis
21. + T-cells
22. Immunosuppression reactivates and disseminates latent murine cytomegalovirus
23. Murine cytomegalovirus DNA in peripheral blood of latently infected mice is detectable only in monocytes and polymorphonuclear leukocytes
24. Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent
25. Latency competence of thirteen HSV-1 temperature-sensitive mutants
26. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response
27. Non-fatal mouse cytomegalovirus hepatitis. Combined morphologic, virologic and immunologic observations
28. Pathogenesis of reactivated latent murine cytomegalovirus infection
29. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice
30. Molecular cloning and restriction endonuclease mapping of the murine cytomegalovirus genome (Smith strain)
31. Depletion of accessory cells by adherence to Sephadex G-10
32. Role of T-lymphocyte subsets in control of cytomegalovirus infection
33. Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence
34. Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors
35. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T-cell clones
36. Principles for adoptive T-cell therapy of human viral diseases
37. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
38. + T lymphocytes
39. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands
40. Severe herpesvirus infections in an adolescent without natural killer cells
41. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target T-cells, and partial restoration by IL2
42. Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo
43. Immune recovery uveitis
44. Fluorescent in vivo tracking of hematopoietic cells. Part I. Technical considerations
45. Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients